Thomas Clark is listed as a director on 2 SEC Form D filings by 1 issuer between Jan 2011 and May 2011: PROTEA BIOSCIENCES INC (Morgantown, WV — biotechnology — 2011; $7.49M reported sold to 84 investors).
What this means One deal on file with the SEC, filed May 2011. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Daniel Flynn (2 shared filings), Ed Roberson (2 shared filings), Jesse Ayers (2 shared filings), Milan Puskar (2 shared filings), Roderick Jackson (2 shared filings) and 6 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.
The issuer belongs to the sponsor group Protea Biosciences (2 issuers, $1.68M reported sold, 2009–2016).
What this means A sponsor group is one team that sets up a new company for each deal. Protea Biosciences has 2 companies on file and $1.68M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 SEC releases, 1 bankruptcy case matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Thomas Clark and found 9 differences: Offering amount changed between filings; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.